期刊文献+

初诊2型糖尿病患者周围神经病变相关危险因素分析 被引量:3

Related risk factors for peripheral neuropathy in patients newly diagnosed as type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨初诊2型糖尿病(T2DM)患者并发糖尿病周围神经病变(DPN)的危险因素。方法 170例初诊T2DM患者,根据有无自觉症状及神经传导速度测定有无异常分为无DPN组60例、DPN组110例。将体重指数(BMI)、血压、入院时随机血糖(RBG)、空腹C肽(FCP)、糖负荷后2小时C肽(2h CP)、糖化血红蛋白(Hb A1c)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、尿酸(UA)、晨尿微量白蛋白/肌酐(UACR)等指标进行单因素分析,对有统计学意义的因素进行多因素logistic非条件回归分析。结果 170例初诊T2DM患者DPN的患病率为64.7%。DPN组年龄、RBG、UACR、Hb A1c高于无DPN组(P<0.05)。多因素logistic非条件回归分析显示,年龄、UACR、Hb A1c为初诊T2DM患者发生并发DPN的危险因素(P<0.05)。结论初诊T2DM患者易并发DPN,年龄、Hb A1c、UACR为初诊T2DM患者发生DPN的危险因素。 Objective To investigate the risk factors for diabetic peripheral neuropathy( DPN) in patients newly diagnosed as type2 diabetes mellitus( T2DM). Methods According to the subjective symptoms and the abnormality of nerve conduction velocity( NCV),170 patients newly diagnosed as T2 DM were divided into non-DPN group( n = 60) and DPN group( n = 110). Body mass index( BMI),blood pressure,random blood glucose( RBG) when admission,fasting C-peptide( FCP),postprandial 2-hour C-peptide( 2h CP),glycosylated hemoglobin( Hb A1c),total cholesterol( TC),triglyceride( TG),low density lipoprotein cholesterol( LDL-C),high density lipoprotein cholesterol( HDL-C),uric acid( UA),the ratio of urinary albumin and creatinine( UACR) were enrolled in univariant analysis. And the factors with statistical significance were enrolled in multivariate unconditional logistic regression analysis. Results The morbidity of DPN in 170 patients newly diagnosed as T2 DM was 64. 7%. Age,RBG,UACR,Hb A1 c of DPN group were higher than those of non-DNP group( P〈0. 05). Multivariate unconditional logistic regression analysis showed that age,UACR and Hb A1 c were the risk factors for DPN in patients newly diagnosed as T2DM( P〈0. 05). Conclusion Patients newly diagnosed as T2 DM are liable to complicated with DPN. Age,Hb A1 c and UACR are the risk factors for the onset of DPN in patients newly diagnosed as T2 DM.
出处 《广西医学》 CAS 2015年第9期1243-1245,共3页 Guangxi Medical Journal
基金 广西科学研究与技术开发计划(桂科攻1140003A-41) 广西柳州市应用技术研究与开发计划项目(2010030716)
关键词 糖尿病周围神经病变 2型糖尿病 初诊 危险因素 Diabetic peripheral neuropathy Type 2 diabetes mellitus Newly diagnosed Risk factor
  • 相关文献

参考文献10

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010版)[M].北京:北京大学医学出版社,2011:1-4.
  • 2钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6. 被引量:2312
  • 3陈晓倩,毕艳,胡云,童国玉,朱大龙.糖尿病周围神经病变患病率及危险因素分析[J].医学研究生学报,2011,24(10):35-38. 被引量:43
  • 4Smith AG,Singleton JR.Impaired glucose tolerance and neurop- athy[J].Neurologist,2008,14(1)23-29.
  • 5Tlie Diabetes Control and Complications Trail Research Group.Hie effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J].N Engl J Med,1993,329(14):977-986.
  • 6United Kingdom Prospective Diabetes Study(UKPDS)Group.Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes[J].Lancet,1998,352(9131):837-853.
  • 7Bonnet CT,Ray C.Peripheral neuropathy may not be the only fundamental reason explaining increased sway in diabetic indi- viduals[J].Clin Biomech,2011,26(7):699-706.
  • 8Elliott J,Tesfaye S,Chaturvedi N,et al.Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors[J].Diabetes Care,2009,32(10):1896-1900.
  • 9宋庆芳,宋光耀.2型糖尿病周围神经病变危险因素分析[J].中国老年学杂志,2009,29(2):222-224. 被引量:22
  • 10Holiner I,Haslinger V,Ltitschg J,et al.Validity of the neu- rological examination in diagnosing diabetic peripheral neu- ropathy[J].Pediatr Neurol,2013,49(3);171-177.

二级参考文献25

  • 1张进,薛波,施弘,钱雪梅,刘芳.糖尿病周围神经病变危险因素分析[J].上海医学,2008,31(10):721-723. 被引量:21
  • 2Harati Y. Diabetic neuropathies : Unanswered questions [J]. Neurol Clin, 2007 ;25 ( 1 ) :303-17.
  • 3Bouhon A J, Vinik AI, Arezzo JC,et al. Diabetic Neuropathies : a statement by the American Diabetes Association [ J ]. Diabetes Care, 2005 ; 28 ( 4 ) : 956-62.
  • 4Vinik AI,Mehrabyan A. Diabetic neuropathies[ J ]. Med Clin North Am, 2004 ; 88:947-99.
  • 5Barbosa AP, Medina JL, Ramos EP, et al. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population[J]. Diabetes Metab,2001 ;27(4) :496-502.
  • 6Shaw JE, Hodge AM, de Courten M,et al. Diabetic neuropathy in mauritius prevalence and risk factors[ J ]. Diabetes Res Clin prac, 1998 ;42 (2) :131-42.
  • 7Perkins BA, Greene DA, Bril V. Glycemic control is related to the morphological severity of diabetic peripheral sensory motor polyneuropathy [J]. Diabetes Care,2001 ;24(4) :748-52.
  • 8Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus[J]. N Engl J Med,1993 ;329(14) :977-86.
  • 9UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes[J]. Lancet, 1998; 352 (9131) :837-53.
  • 10Smith AG,Singleton JR. Impaired glucose tolerance and neuropathy[J]. Neurologist,2008 ; 14 ( 1 ) :23-9.

共引文献2422

同被引文献30

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部